Personalis to Participate at the Needham Virtual Cancer Diagnostics 1x1 ConferenceBusiness Wire • 08/12/20
Personalis, Inc. (PSNL) CEO John West on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
Personalis, Inc. Launches NeXT Liquid Biopsy™, A High-Performance, Exome-Wide Liquid Biopsy PlatformBusiness Wire • 08/03/20
Personalis to Announce Second Quarter 2020 Financial Results on August 6, 2020Business Wire • 07/23/20
Personalis Further Expands Leadership Team With Appointment of Leslie Grab, VP of Intellectual Property and John Lyle, VP of Assay Research and DevelopmentBusiness Wire • 07/16/20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Personalis, Inc. - PSNLPRNewsWire • 06/24/20
PSNL Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Personalis, Inc. and Encourages Investors to Contact the FirmPRNewsWire • 06/02/20
Personalis, Inc. (PSNL) CEO John West on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/09/20
Personalis, Inc. (PSNL) CEO John West on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/26/20
Personalis, Inc. (PSNL) CEO John West on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/15/19
Personalis, Inc. (PSNL) CEO John West on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/14/19